Feature Health News Supply chain

MediLedger: Pharmaceutical industry’s blockchain network

pharmaceuticals
Today many industries have one or more blockchain consortia tackling industry business problems. Few have the same urgency as the US pharmaceutical sector. The Drug Supply Chain Security Act (DSCSA) phases in through to 2023, with a deadline for returns in November 2019. The legislation requires drugs to be serialized and traceable.
Business case
Right now blockchain and drug quality are somewhat topical. China has suffered another scandal where vaccines given to babies were ineffective. The public is demanding a solution, and blockchain can play a part. MediLedger aims to be the industry consortium to tackle serialization and other business problems.

Article continues …

subscriber padlock

Want the full story? Pro subscribers get complete articles, exclusive industry analysis, and early access to legislative updates that keep you ahead of the competition. Join the professionals who are choosing deeper insights over surface level news.


Image Copyright: MrHamster / DepositPhotos